Hospital & Health Care - Vancouver, British Columbia, Canada
Transplantation is the optimal treatment for patients with kidney failure, but rejection still causes premature graft loss in as many as 30 per cent of recipients. This project aims to cut the rejection rate by in half by using genomic technologies to improve the matching of donors and recipients, to monitor the immune response for rejection, and to develop personalized drug treatment regimes for each recipient. It offers the potential for $1 billion in healthcare savings over the next 15 years.
Nginx
WordPress.org
Google Font API
YouTube
Mobile Friendly